![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/kechow-pharma-announces-nmpa-approval-of-tunlametinib-hl-085-as-the-first-targeted-therapy-for-patients-with-nras-mutated-advanced-melanoma-and-previously-treated-with-pd-1pd-l1-302091342.html